Wefight

Wefight, founded in 2017 and headquartered in France, is positioning itself as a pivotal player in the digital health sector. The company is renowned for its Virtual Companion, named Vik, designed to assist patients with cancer and chronic diseases. Through the use of advanced technologies such as artificial intelligence and natural language processing, Wefight collaborates with medical experts to deliver solutions that are tailored to the specific needs of patients.

The Vik companion stands out for its 24/7 service, offering patients timely information and continuous support throughout their healthcare journey. In addition to its core offering, Wefight furthers understanding through Vik Studies, enabling stakeholders to capture the authentic patient perspective and refine patient-centric strategies.

The company last secured a €10.00M Series A investment on 14 September 2021, with backing from Investir &+ and Digital Health Ventures. This funding underscores investor confidence in Wefight's innovative approach and growth potential.